2019
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Reviews 2019, 36: 70-87. PMID: 31101526, DOI: 10.1016/j.blre.2019.04.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAcute myeloid leukemiaPatient outcomesMyeloid leukemiaAllogeneic stem cell transplantationEtiology of AMLMinority of patientsStem cell transplantationAge-adjusted incidenceMost older individualsMyeloid progenitor cellsIntensive chemotherapyActive therapyClear etiologyOlder patientsRefractory diseaseSupportive careCurative therapyMedian agePoor prognosisShorter survivalCell transplantationDisease characteristicsEnvironmental DNA-damaging agentsMalignant disordersTherapeutic advances
2007
Clustering in the incidence of myelodysplastic syndromes
Ma X, Selvin S, Raza A, Foti K, Mayne ST. Clustering in the incidence of myelodysplastic syndromes. Leukemia Research 2007, 31: 1683-1686. PMID: 17507092, DOI: 10.1016/j.leukres.2007.03.032.Peer-Reviewed Original ResearchConceptsIncidence of MDSMyelodysplastic syndromePopulation-based cancer registry dataEtiology of MDSPopulation-based dataCancer registry dataGroup of malignanciesPoor prognosisObscure etiologyPotential clusteringRegistry dataHigh incidenceEtiologic hypothesesLarger sample sizeIncidenceSyndromeP-valueEtiologyFuture studiesState of ConnecticutCensus tractsSample sizeIntriguing findingPrognosisMalignancy